Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Shockwave: Disruption for A Better Fit

NCT: NCT05147363 · WITHDRAWN

NCT IDNCT05147363
StatusWITHDRAWN
Start Date2020-12-07
Completion2022-07-22

Brief Summary

Recent clinical trial results demonstrate that IVL can increase lumen area by emitting sonic pressure waves, with less inflation pressure as compared to traditional angioplasty balloon dilation and resulting in minimal trauma to the vessel. Therefore, the use of IVL prior to placement of a stent for severely calcified femoral popliteal arteries may be associated with more successful stent implants and better long-term patency, resulting in a decrease in cardiovascular events. The investigator will evaluate the success by defining as lesion stenosis less than 30% and no evidence of Major Adverse Cardiac Event including death or any amputation of the index limb within 30 days of the procedure.

Frequently Asked Questions

What is Shockwave: Disruption for A Better Fit?

Shockwave: Disruption for A Better Fit is a clinical trial registered under NCT05147363. Current status: WITHDRAWN.

What is the status of NCT05147363?

The current status of NCT05147363 (Shockwave: Disruption for A Better Fit) is: WITHDRAWN.

When did Shockwave: Disruption for A Better Fit start?

Shockwave: Disruption for A Better Fit started on 2020-12-07.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.